Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Classical hematology 1

Conditions

Thrombocytopenia 5Leukemia, Myeloid, Acute 3Myelodysplastic Syndromes 2Sarcoma 1Purpura, Thrombocytopenic, Idiopathic 1Myeloproliferative Disorders 1Leukemia 1Jacobs syndrome 1Healthy Adults 1

Interventions

Doxorubicin 33pembrolizumab 16Gemcitabine 15eribulin 10Irinotecan 10olaratumab 9Trabectedin 9pazopanib 8Docetaxel 8Injections 7Cyclophosphamide 7Nivolumab 6Fluorouracil 6anlotinib 5Temozolomide 5Ipilimumab 5Ifosfamide 5Bevacizumab 5tazemetostat 4ridaforolimus 4Drug Therapy 4Cetuximab 4Carboplatin 4toripalimab 3surufatinib 3spartalizumab 3ganitumab 3entrectinib 3conatumumab 3belinostat 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
INDUSTRY × Sarcoma × eltrombopag × Clear all
NCT00358540 2017-11-13

Dose Finding Study Of Oral Eltrombopag In Patients With Sarcoma Receiving Adriamycin And Ifosfamide

GlaxoSmithKline

Phase 1 Completed
18 enrolled
Classical hematologySarcoma

Sarcoma, Thrombocytopenia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡